Keywords: msd, withdraws, ma, vorinostat, eu, merck, sharp

MSD withdraws MA for vorinostat in EU

Article | 23 February 2009

Print This

Merck Sharp & Dohme, the UK subsidiary of US drug major Merck & Co, has withdrawn its application for a centralized marketing ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in